Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × cisplatin-guanosine adduct × Clear all

NCT02610556 2016-05-26

Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma